/* Hide loading templates */ #js-listings:before, #js-listings:after, .loading-page:before, .loading-page, .loading-page:after, .loading-spinner:before, .loading-spinner:after, body:not(.ember-application):before, body:not(.ember-application):after, /* Hide ui that requires scripting */ #stream_launch_widget, .btn-group { display: none !important; } /* show hidden page elements */ body>#full-page-viewport-wrapper, body>#navigation-menu { display: inherit; } /* show images */ #main img, #series img, #related img { opacity: 1; } /* style warning message */ .noscript-warning { color: #003666; margin: 0 2rem 2rem 2rem; padding: 1.5rem; background: #EBC0B7; border-radius: 5px; } It looks like there's an issue with JavaScript in your browser. For a better experience, we recommend that you enable JavaScript. Go to https://www.whatismybrowser.com/guides/how-to-enable-javascript/ to learn more.

Dr. David Koepsell,

Dr. David Koepsell, appears in the following:

Underreported: Gene Patenting

Thursday, October 22, 2009

Twenty percent of the human genome has been patented by biotechnology companies, universities, and research institutions. The patenting of two genes associated with breast and ovarian cancer is also the subject of a lawsuit filed by the ACLU and the Public Patent Foundation against Myriad Genetics, a company that offers ...